Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...

Transcranial magnetic stimulation (TMS) was first approved for the treatment of major depressive disorder (MDD) in 2008. Because it worked well for depression by using a strong magnetic field to ...

BrainsWay Ltd. BWAY recently announced an expansion of insurance coverage for its Deep TMS therapy in adolescent depression.

BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain ...

(RTTNews) - Neuronetics, Inc. (STIM), a neurohealth technology company, on Wednesday announced the publication of two significant peer-reviewed studies in the inaugural issue of the Transcranial ...

Sponsored: The holidays are considered a time of joy, but others face challenges. TMS Therapy at Sunrise Psychiatry may help.

New findings from researchers at UCLA Health suggest that measuring changes in how pupils react to light could help predict recovery from depression and personalize transcranial magnetic stimulation ...

Please provide your email address to receive an email when new articles are posted on . Transcranial magnetic stimulation targets the central executive network. 80% of patients responded by 20 ...

KANAWHA COUNTY, W.Va. (WCHS) — With the new year here and winter weather upon us, many people are dealing with seasonal depression. Studies show that depression is impacting nearly 21 million ...

DULUTH — Depression had been an uninvited aspect of Gail Sundstrum’s life since she experienced her first episode with it in 1993. “I couldn’t stop shaking. I couldn’t stop crying. I couldn’t eat. I ...

NEW YORK ― Transcranial magnetic stimulation (TMS) is a cost-effective treatment option for patients with resistant major depressive disorder (MDD), according to a new economic analysis. "It's mainly ...